TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vitrolife AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
3,609,000
|
3,512,000
|
3,234,000 |
| Financial expenses |
134,000
|
142,000
|
119,000 |
| Earnings before taxes |
674,000
|
-3,712,000
|
537,000 |
| EBITDA |
1,131,000
|
1,117,000
|
1,050,000 |
| Total assets |
17,446,000
|
16,329,000
|
20,551,000 |
| Current assets |
2,357,000
|
1,914,000
|
1,573,000 |
| Current liabilities |
704,000
|
557,000
|
621,000 |
| Equity capital |
13,640,000
|
12,722,000
|
16,736,000 |
| - share capital |
28,000
|
28,000
|
28,000 |
| Employees (average) |
1,082
|
1,084
|
1,117 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
78.2%
|
77.9%
|
81.4% |
| Turnover per employee |
3,335
|
3,240
|
2,895 |
| Profit as a percentage of turnover |
18.7%
|
-105.7%
|
16.6% |
| Return on assets (ROA) |
4.6%
|
-21.9%
|
3.2% |
| Current ratio |
334.8%
|
343.6%
|
253.3% |
| Return on equity (ROE) |
4.9%
|
-29.2%
|
3.2% |
| Change turnover |
97,000
|
278,000
|
1,553,196 |
| Change turnover % |
3%
|
9%
|
92% |
| Chg. No. of employees |
-2
|
-33
|
639 |
| Chg. No. of employees % |
0%
|
-3%
|
134% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.